中药与地高辛相互作用:临床与研究进展
该综述检索1960年1月至2022年8月多个数据库,共纳入49篇文献,包括临床报告、药理实验和体外实验。文章概述了影响地高辛药理学的中药制剂及其机制,涉及胃肠动力、胃液pH、P-糖蛋白水平、累积药理效应及心脏敏感性等,旨在为临床安全合理联用提供参考。
要点
- 地高辛有效血药浓度0.5-2.0 ng/mL,大于2 ng/mL为中毒,治疗窗窄且个体差异大。
- 中药制剂可通过影响胃肠动力、胃液pH、P-糖蛋白水平等机制改变地高辛药理学。
- 现有研究结果存在争议,联用时需警惕不良反应,尚需深入研
核心结论
- 地高辛与中药制剂联用常见,需了解相互作用以避免不良反应并提高疗效与安全性。
研究设计与样本
- 综述检索PubMed、MEDLINE、Cochrane Library、Web of Science、CNKI和WANFANG Data,检索1960年1月1日至2022年8月1日发表文献,共获得49篇。
主要发现
- 纳入文献包括临床报告、药理实验和体外实验,涉及单体成分、单味药及中成药与地高辛的相互作用。
- 中药制剂可能通过影响胃肠动力或胃液pH、调节P-糖蛋白水平、发挥累积药理效应及增强心脏对地高辛敏感性等机制影响地高辛药理学。
- 现有研究结果存在争议,可能受中药成分复杂性、药理效应及地高辛浓度测定方法敏感性等因素影响。
关键数值与推荐
- 《中华人民共和国药典》2010年版规定地高辛有效血药浓度范围为0.5-2.0 ng/mL,血药浓度大于2 ng/mL时为中毒。
临床怎么用
- 临床联用地高辛与中药制剂时,应关注可能的相互作用,监测地高辛血药浓度及不良反应。
- 对含影响胃肠动力、P-糖蛋白或具有累积药理效应的中药制剂,联用时应加强评估。
局限性
- 现有研究结果存在争议,受中药成分复杂性、药理效应及地高辛浓度测定方法敏感性等因素影响,需进一步深入研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Digoxin is one of the most widely and commonly used cardiac drug, which plays an irreplaceable role in treating heart failure and arrhythmia. The 2010 Edition of Pharmacopoeia of the People's Republic of China stipulates that the effective range of digoxin plasma concentration is 0.5-2.0 ng/mL and it is toxic at plasma concentration >2 ng/mL. Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed. It is often used in combination with other drugs, but drug interactions have a great impact on the plasma concentration of digoxin and lead to adverse reactions (ADRs), such as poisoning. Most of the reported drug interactions are with Western drugs. However, there are many combinations of traditional Chinese medicine (TCM) and Western drugs, TCM interacting with digoxin comprises monomer components, single medicines, and Chinese patent medicines. Aim of the study: We aimed i) to provide an overview of the TCM formulations affecting the pharmacology of digoxin and their mechanisms of action and ii) to provide a theoretical reference for the safe and rational use of digoxin in combination with TCM in clinical practice and to avoid ADRs. Methods: A literature search of electronic databases, including PubMed, MEDLINE, Cochrane Library, Web of Science, China National Knowledge Infrastructure, and WANFANG Data, was performed to search for articles published between 1 January 1960, and 1 August 2022. Search terms used included "digoxin," "traditional Chinese medicine," "Chinese patent medicine," and "adverse reactions" and their combinations. Results: A total of 49 articles were obtained, including clinical reports, pharmacological experiments and in vitro experiments. The mechanisms of action affecting the pharmacology of digoxin are complex. TCM formulations may affect the pharmacology of digoxin in vivo by influencing gastrointestinal motility or gastric juice pH, regulating P-glycoprotein levels, exerting cumulative pharmacological effects, and enhancing the sensitivity of the heart to digoxin. Although studies have shown that some TCM formulations interact with digoxin, they may be influenced by the complexity of the composition and the pharmacological effects of the TCM, the sensitivity of digoxin concentration determination methods, etc. The results of existing studies are controversial and further in-depth studies are required. Conclusion: Combinations of digoxin and TCM formulations are commonly used. This article serves as a reference to understand the interactions between TCM formulations and digoxin to avoid the occurrence of ADRs and improve the efficacy and safety of digoxin.
引用
- Zhuang W, He T, Jia BB, et al. Interaction between Chinese medicine and digoxin: Clinical and research update. Front Pharmacol. 2023. PMID: 36825153. doi:10.3389/fphar.2023.1040778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。